To include your compound in the COVID-19 Resource Center, submit it here.

Intercell starts Phase II HCV study

Intercell (Vienna, Austria) started a dose-escalation European Phase

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE